Annual Accounts Receivable
$1.21 B
+$15.00 M+1.26%
31 December 2023
Summary:
Quest Diagnostics Incorporated annual accounts receivable is currently $1.21 billion, with the most recent change of +$15.00 million (+1.26%) on 31 December 2023. During the last 3 years, it has fallen by -$228.00 million (-15.86%). DGX annual accounts receivable is now -20.39% below its all-time high of $1.52 billion, reached on 31 December 2020.DGX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$1.38 B
+$57.00 M+4.32%
30 September 2024
Summary:
Quest Diagnostics Incorporated quarterly accounts receivable is currently $1.38 billion, with the most recent change of +$57.00 million (+4.32%) on 30 September 2024. Over the past year, it has increased by +$166.00 million (+13.72%). DGX quarterly accounts receivable is now -9.47% below its all-time high of $1.52 billion, reached on 31 December 2020.DGX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DGX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +13.7% |
| 3 y3 years | -15.9% | -4.3% |
| 5 y5 years | +13.8% | +29.4% |
DGX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -15.9% | +1.3% | -4.3% | +15.2% |
| 5 y | 5 years | -20.4% | +13.8% | -9.5% | +41.6% |
| alltime | all time | -20.4% | +306.4% | -9.5% | +170.7% |
Quest Diagnostics Incorporated Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.38 B(+4.3%) |
| June 2024 | - | $1.32 B(-0.2%) |
| Mar 2024 | - | $1.32 B(+9.3%) |
| Dec 2023 | $1.21 B(+1.3%) | $1.21 B(-5.5%) |
| Sept 2023 | - | $1.28 B(+3.7%) |
| June 2023 | - | $1.24 B(-1.5%) |
| Mar 2023 | - | $1.25 B(+4.9%) |
| Dec 2022 | $1.20 B(-16.9%) | $1.20 B(-6.6%) |
| Sept 2022 | - | $1.28 B(-1.0%) |
| June 2022 | - | $1.29 B(-5.7%) |
| Mar 2022 | - | $1.37 B(-4.7%) |
| Dec 2021 | $1.44 B(-5.4%) | $1.44 B(-2.4%) |
| Sept 2021 | - | $1.47 B(+17.4%) |
| June 2021 | - | $1.25 B(-9.2%) |
| Mar 2021 | - | $1.38 B(-9.1%) |
| Dec 2020 | $1.52 B(+43.0%) | $1.52 B(+7.0%) |
| Sept 2020 | - | $1.42 B(+26.2%) |
| June 2020 | - | $1.13 B(+15.8%) |
| Mar 2020 | - | $972.00 M(-8.6%) |
| Dec 2019 | $1.06 B(+5.0%) | $1.06 B(-4.8%) |
| Sept 2019 | - | $1.12 B(+2.7%) |
| June 2019 | - | $1.09 B(+0.8%) |
| Mar 2019 | - | $1.08 B(+6.6%) |
| Dec 2018 | $1.01 B(+9.5%) | $1.01 B(-7.7%) |
| Sept 2018 | - | $1.10 B(+4.0%) |
| June 2018 | - | $1.05 B(+2.8%) |
| Mar 2018 | - | $1.03 B(+11.0%) |
| Dec 2017 | $924.00 M(-0.2%) | $924.00 M(-3.8%) |
| Sept 2017 | - | $960.00 M(+1.4%) |
| June 2017 | - | $947.00 M(-1.4%) |
| Mar 2017 | - | $960.00 M(+3.7%) |
| Dec 2016 | $926.00 M(+2.8%) | $926.00 M(-4.1%) |
| Sept 2016 | - | $966.00 M(-0.9%) |
| June 2016 | - | $975.00 M(+2.4%) |
| Mar 2016 | - | $952.00 M(+5.7%) |
| Dec 2015 | $901.00 M(-3.3%) | $901.00 M(-1.4%) |
| Sept 2015 | - | $914.00 M(-2.5%) |
| June 2015 | - | $937.00 M(-1.3%) |
| Mar 2015 | - | $949.00 M(+1.8%) |
| Dec 2014 | $932.00 M(+9.4%) | $932.00 M(-2.2%) |
| Sept 2014 | - | $953.00 M(-1.0%) |
| June 2014 | - | $963.00 M(-1.4%) |
| Mar 2014 | - | $977.00 M(+14.7%) |
| Dec 2013 | $852.00 M(-1.7%) | $852.00 M(-7.5%) |
| Sept 2013 | - | $920.83 M(-2.7%) |
| June 2013 | - | $946.75 M(+1.8%) |
| Mar 2013 | - | $929.97 M(+7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $867.00 M(-4.4%) | $867.00 M(-6.8%) |
| Sept 2012 | - | $930.73 M(-1.1%) |
| June 2012 | - | $941.47 M(-3.3%) |
| Mar 2012 | - | $973.89 M(+7.4%) |
| Dec 2011 | $906.46 M(+7.2%) | $906.46 M(-3.2%) |
| Sept 2011 | - | $936.26 M(+0.7%) |
| June 2011 | - | $929.37 M(-1.2%) |
| Mar 2011 | - | $940.36 M(+11.2%) |
| Dec 2010 | $845.30 M(+2.2%) | $845.30 M(-2.8%) |
| June 2010 | - | $869.64 M(+0.5%) |
| Mar 2010 | - | $865.16 M(+4.6%) |
| Dec 2009 | $827.34 M(-0.7%) | $827.34 M(-6.9%) |
| Sept 2009 | - | $888.29 M(-0.9%) |
| June 2009 | - | $896.53 M(+0.9%) |
| Mar 2009 | - | $888.25 M(+6.6%) |
| Dec 2008 | $832.87 M(-5.6%) | $832.87 M(-6.2%) |
| Sept 2008 | - | $888.12 M(-3.7%) |
| June 2008 | - | $922.51 M(-2.7%) |
| Mar 2008 | - | $947.74 M(+7.5%) |
| Dec 2007 | $881.97 M(+13.9%) | $881.97 M(-8.4%) |
| Sept 2007 | - | $962.86 M(-1.0%) |
| June 2007 | - | $973.07 M(+20.0%) |
| Mar 2007 | - | $810.58 M(+4.7%) |
| Dec 2006 | $774.41 M(+5.7%) | $774.41 M(-9.6%) |
| Sept 2006 | - | $857.03 M(+7.1%) |
| June 2006 | - | $800.28 M(+3.2%) |
| Mar 2006 | - | $775.72 M(+5.8%) |
| Dec 2005 | $732.91 M(+12.9%) | $732.91 M(+5.6%) |
| Sept 2005 | - | $693.79 M(+0.1%) |
| June 2005 | - | $693.38 M(-1.3%) |
| Mar 2005 | - | $702.42 M(+8.2%) |
| Dec 2004 | $649.28 M(+6.6%) | $649.28 M(-5.4%) |
| Sept 2004 | - | $686.04 M(+1.2%) |
| June 2004 | - | $677.71 M(+4.2%) |
| Mar 2004 | - | $650.51 M(+6.8%) |
| Dec 2003 | $609.19 M(+16.7%) | $609.19 M(-5.4%) |
| Sept 2003 | - | $643.84 M(+2.5%) |
| June 2003 | - | $628.40 M(+2.4%) |
| Mar 2003 | - | $613.64 M(+17.5%) |
| Dec 2002 | $522.13 M(+2.7%) | $522.13 M(-9.4%) |
| Sept 2002 | - | $576.46 M(-3.5%) |
| June 2002 | - | $597.67 M(+9.0%) |
| Mar 2002 | - | $548.40 M(+7.9%) |
| Dec 2001 | $508.34 M(+70.7%) | $508.34 M(-1.0%) |
| Sept 2001 | - | $513.64 M(-1.4%) |
| June 2001 | - | $520.87 M(+2.3%) |
| Mar 2001 | - | $509.27 M |
| Dec 1996 | $297.74 M | - |
FAQ
- What is Quest Diagnostics Incorporated annual accounts receivable?
- What is the all time high annual accounts receivable for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated quarterly accounts receivable year-on-year change?
What is Quest Diagnostics Incorporated annual accounts receivable?
The current annual accounts receivable of DGX is $1.21 B
What is the all time high annual accounts receivable for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high annual accounts receivable is $1.52 B
What is Quest Diagnostics Incorporated quarterly accounts receivable?
The current quarterly accounts receivable of DGX is $1.38 B
What is the all time high quarterly accounts receivable for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high quarterly accounts receivable is $1.52 B
What is Quest Diagnostics Incorporated quarterly accounts receivable year-on-year change?
Over the past year, DGX quarterly accounts receivable has changed by +$166.00 M (+13.72%)